Join Drs Forest Arnold and Brittanie West as they discuss their personal experience preventing and managing RSV in adults in their Appalachian communities.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/998284. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview
RSV in Rural Communities: Lessons From Appalachia https://www.medscape.com/viewarticle/985982
CDC RSV Surveillance and Research https://www.cdc.gov/rsv/research/index.html
American Hospital Association Rural Report rural-report-2019.pdf (aha.org) https://www.aha.org/system/files/2019-02/rural-report-2019.pdf
Physician Learning Preferences physician-learning-report-2022.pdf (doximity.com) https://press.doximity.com/reports/physician-learning-report-2022.pdf
Do You Spend More Time Searching for Medical Information Than the Average American? https://swnsdigital.com/us/2020/11/do-you-spend-more-time-searching-for-medical-information-than-the-average-american/
One Assay to Test Them All: Multiplex Assays for Expansion of Respiratory Virus Surveillance https://pubmed.ncbi.nlm.nih.gov/37168265/
Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET) https://www.cdc.gov/rsv/research/rsv-net/index.html
RSVVaxView https://www.cdc.gov/vaccines/imz-managers/coverage/rsvvaxview/index.html
REVIRAL 1 https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/reviral-1/
A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein https://pubmed.ncbi.nlm.nih.gov/31712214/